Advanced Wound Care Market Forecast 2016-2026: Revenue Prospects for Active Wound Care Dressings, Wound Care Devices and Wound Care Biologics

07 September 2016
Pharma

A new report by visiongain predicts that the Advanced Wound Care market will reach $17.7bn in 2020. This forecast and others appear in Advanced Wound Care Market Forecast 2016-2026: Revenue Prospects for Active Wound Care Dressings, Wound Care Devices and Wound Care Biologics published in April 2016. Visiongain is a business information provider based in London, UK.

The Advanced Wound Care Market Forecast 2016-2026 report examines the current and future trends in the Advanced Wound Care Market with particular focus on recent pivotal developments in the sector involving product launches, company acquisitions, and changes in regulatory and reimbursement policies. These developments in addition to changes in population demographics are changing the landscape of advanced wound care.

Wound Dressings are applied to a wound to promote healing and prevent further harm. A dressing is designed to be in direct contact with the wound. Wound dressings are a fundamental part of wound care in general. A dressing does not heal the wound; it provides an optimal environment for healing to take place. Advanced wound care encompasses the following product segments: active wound dressings, wound care devices, and wound care biologics.

The advanced wound care market is impacted by the ageing population, rising prevalence of diabetes and obesity, and growing patient awareness as well as pressure on healthcare systems to reduce hospital stays and treatment costs. The advanced wound care market will be increasingly expected to innovate in order to meet these demands.

In this report, we examine in detail the factors which are driving the Advanced Wound Care market growth and the key companies currently operating in the advanced wound care market including their product pipelines. We also examine key national markets and discuss trends and variations within these markets, alongside an analysis of advanced wound care products type their relative strengths.

The Advanced Wound Care categories examined in this report are: active wound care dressings, wound care devices, and wound care biologicals. National Markets focused on are the US, China, Japan, EU5 (Germany, UK, Italy, France and Spain), Brazil, Russia, India and South Korea.

Using both primary and secondary research, forecasts have been built for the major submarkets, leading products and leading national and regional markets, accompanied by text giving a thorough explanation of events thought to shape the market currently and in the future.

Also included is analysis of the current leading players in the Advanced Wound Care Market. Historical financial performance (where available) is analysed, along with a breakdown of each company’s leading products, and recent merger & acquisition information, with an analysis of news that may influence the course of the company. The report discusses selected leading companies which hold significant shares of the market. These companies include Smith & Nephew, Acelity, Molnlycke, Coloplast, ConvaTec, and Organogeneis. Visiongain’s report also discusses key economic points, commercial news, and analysis of strengths, weaknesses, opportunities and threats.

Advanced Wound Care Market Forecast 2016-2026: Revenue Prospects for Active Wound Care Dressings, Wound Care Devices and Wound Care Biologics adds to visiongain’s range of analytical reports on industries and markets in healthcare. For an executive summary please contact: Email: Sara Peerun on sara.peerun@visiongainglobal.com Tel: +44 (0) 20 7336 6100

Notes for Editors

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions.

Recent News

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

Read

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

Read

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

Read

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever